EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pre‐Diagnostic Circulating Glycerolipids Are Enriched in Men Who Develop Advanced Prostate Cancer: A Nested Case–Control Study

Rebecca E. Graff, Harriett Fuller, Kathryn M. Wilson, Barbra A. Dickerman, June M. Chan, Philip W. Kantoff, Xiaoshuang Feng, Clary B. Clish, Matthew G. Vander Heiden, Burcu F. Darst, Ericka M. Ebot, Lorelei A. Mucci

International Journal of Cancer · 21.11.2026

DOI: 10.1002/ijc.70830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 21.11.2026. Verfasst von Rebecca E. Graff und 11 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Prostate Cancer Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Few studies with pre‐diagnostic samples have estimated associations between circulating metabolites and risk of advanced prostate cancer. We performed untargeted metabolomic profiling of pre‐diagnostic blood samples from 212 advanced prostate cancer cases (stage ≥ T3b or lethal during follow‐up) and 212 matched controls from the Health Professionals Follow‐up Study. 243 metabolites were assayed using liquid chromatography–tandem mass spectrometry (Broad Institute) and met quality control standards. We used multivariable conditional logistic regression to generate odds ratios (OR) and 95% confidence intervals (95% CI) for associations between individual metabolites and risk of advanced prostate cancer, and conducted metabolite set enrichment tests to identify metabolite classes enriched in advanced prostate cancer. Subgroup analyses were conducted by body mass index (BMI) and time between blood draw and diagnosis. Levels of 16 lipid metabolites were nominally associated with advanced prostate cancer at p < 0.05, though none were statistically significant after multiple testing correction. The strongest signals were for C56:1 triacylglycerol (TAG; OR: 1.34, 95% CI: 1.07–1.67) and C38:4 diacylglycerol (DAG; OR: 1.27, 95% CI: 1.04–1.55). Enrichment analyses revealed six metabolite classes associated with advanced prostate cancer after multiple testing adjustment, the top four of which were DAGs and TAGs: DAGs overall ( p = 3.4E−07), unsaturated DAGs ( p = 5.9E−07), unsaturated TAGs ( p = 2.3E−06), and TAGs overall ( p = 2.4E−06). 48 metabolites were nominally associated with advanced prostate cancer among individuals with BMI < 25 kg/m 2 ; only three demonstrated nominal associations in individuals with BMI ≥ 25 kg/m 2 . These findings suggest a possible relationship between circulating pre‐diagnostic lipid levels and aggressive prostate cancer risk, particularly in lean individuals.

Förderung

  • Prostate Cancer Foundation

Zitieren

APA

Graff, R. E., Fuller, H., Wilson, K. M., Dickerman, B. A., Chan, J. M., Kantoff, P. W., Feng, X., Clish, C. B., Heiden, M. G. V., Darst, B. F., Ebot, E. M., & Mucci, L. A. (2026). Pre‐Diagnostic Circulating Glycerolipids Are Enriched in Men Who Develop Advanced Prostate Cancer: A Nested Case–Control Study. International Journal of Cancer. https://doi.org/10.1002/ijc.70830

Vancouver

Graff RE, Fuller H, Wilson KM, Dickerman BA, Chan JM, Kantoff PW, et al. Pre‐Diagnostic Circulating Glycerolipids Are Enriched in Men Who Develop Advanced Prostate Cancer: A Nested Case–Control Study. International Journal of Cancer. 2026. doi:10.1002/ijc.70830

BibTeX
@article{Graff2026,
  author = {Graff, Rebecca E. and Fuller, Harriett and Wilson, Kathryn M. and Dickerman, Barbra A. and Chan, June M. and Kantoff, Philip W. and Feng, Xiaoshuang and Clish, Clary B. and Heiden, Matthew G. Vander and Darst, Burcu F. and Ebot, Ericka M. and Mucci, Lorelei A.},
  title = {Pre‐Diagnostic Circulating Glycerolipids Are Enriched in Men Who Develop Advanced Prostate Cancer: A Nested Case–Control Study},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70830}
}
Kostenlos starten →